Additional characterization of tumor markers for BLT-derived GBM8 and GBM18 was performed, including SOX2 (Supplementary Figures 2B, C), CD31 (Supplementary Figures 2D, E), and Ki67 (Supplementary Figures 2F, G). This evidence concerns the gene MKI67 and neoplasm.